Clinical trials
Terminated Phase 2 Lymphoproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Children's Hospital Los Angeles | 1 |
| European Association of Urology Research Foundation | 1 |
| Gilead Sciences | 1 |
| HemaQuest Pharmaceuticals Inc. | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Seagen Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 13 |
| Lymphoma | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphatic Diseases | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Immune System Diseases | 4 |
| Immunoproliferative Disorders | 4 |
| Lymphoma, T-Cell, Cutaneous | 4 |
| Mycosis Fungoides | 4 |
| Neoplasms | 4 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.